Global Biosimilars Market Forecast 2013-2021 by Product Types, Application, and Geography


Posted September 27, 2016 by harrythomson82

Biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of pharmaceutical drugs.
 
Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. When the patent of brand drug is expired, pharmaceutical companies are planning to develop off-patent biologics i.e. biosimilars that offer similar biological activity. In short, biosimilars are analogs of generic biologics which are previously available as patented pharmaceutical drugs.

Biosimilars Market Geography Analysis

Based on geography, biosimilars market is segmented into North America, Europe, Asia Pacific and Rest of the World. Rising demand for biosimilar products drives the North America biosimilar market growth. Moreover, European countries also considered as the potential market for the biosimilars owing to the increasing research and development activities by domiciled companies to develop novel biosimilars coupled with government support. For example, Sandoz Pharma, German company developed Binocrit solution for injection for the treatment of a patient with chronic kidney failure. This biosimilar is considered as the affordable and high quality and has proven clinical equivalence and comparability to the originator pharmaceutical molecule. Thus, these types of initiatives would, in turn, increase the utilization of biosimilars, leading to the market growth.

Table of Content
1. EXECUTIVE SUMMARY
a. Research Scope
i. Market Definition
ii. Market Segmentation
iii. Research Methodology
b. Executive Summary
i. Market Summary
ii. Comparative Analysis
2. MARKET DYNAMICS
a. Drivers
b. Restraints
c. Opportunities
d. Trends
3. INDUSTRY ANALYSIS
a. Value Chain Analysis
b. Regulatory Framework Analysis
c. Reimbursement Landscape
d. New Product Approval Analysis
e. Event Impact Analysis
f. Pipeline Product Analysis
g. Market Attractiveness Analysis (Developed Regions v/s Developing Regions)
4. BIOSIMILARS MARKET, BY PRODUCT TYPES
a. Introduction
b. Recombinant Non-Glycosylated Proteins
c. Recombinant Glycosylated Proteins
d. Recombinant Peptides
e. Others
5. BIOSIMILARS MARKET, BY APPLICATION
a. Introduction
b. Oncology
c. Blood Disorders
d. Infectious Diseases
e. Autoimmune Diseases
f. Others
6. BIOSIMILARS MARKET, BY GEOGRAPHY
a. Introduction
b. North America
i. U.S.
ii. Canada
c. Europe
i. France
ii. Germany
iii. U.K
iv. Rest of Europe
d. Asia Pacific (APAC)
i. China
ii. India
iii. Japan
iv. Rest of APAC
e. Rest of the World (ROW)
i. Latin America
ii. The Middle East and Africa
7. COMPETITIVE LANDSCAPE
a. Market Share Analysis, by Key Players
b. Market Positioning of Key Players
c. Key Innovator Companies
8. KEY MARKET PLAYERS
a. Amgen
b. Actavis
c. Biocon Ltd.
d. Sandoz Pharma
e. Stada Arzneimittel AG
f. Hospira, Inc.
g. Cipla Ltd.
h. Wockhardt Ltd.
i. Others
9. SCALAR 360 DEGREE MARKET PERSPECTIVE
10. APPENDIX
a. Definitions
b. Acronyms
c. Contact Us
d. Disclaimer
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Scalar Market Research
Website Global Biosimilars Market Forecast 2013-2021
Phone 1-800-213-5170
Business Address W Bryn Mawr Ave,
Suite 1300 Chicago, IL 60631
Country United States
Categories Biotech
Tags biosimilars market , biosimilars market report , global biosimilars market
Last Updated September 27, 2016